Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib: Analysis of the Phase III TIVO-3 Trial.
Oncologist. 2024 Mar 4;29(3):254-262. doi: 10.1093/oncolo/oyad348.
Oncologist. 2024.
PMID: 38262444
Free PMC article.
Activity of Tivozanib in Non-clear Cell Renal Cell Carcinoma: Subgroup Analysis From a Phase II Randomized Discontinuation Trial.
Barata PC, Chehrazi-Raffle A, Allman KD, Asnis-Alibozek A, Kasturi V, Pal SK.
Barata PC, et al.
Oncologist. 2023 Oct 3;28(10):894-900. doi: 10.1093/oncolo/oyad132.
Oncologist. 2023.
PMID: 37315114
Free PMC article.
Clinical Trial.
Item in Clipboard
Cost of care for malignant and benign renal masses.
Asnis-Alibozek AG, Fine MJ, Russo P, McLaughlin T, Farrelly EM, LaFrance N, Lowrance W.
Asnis-Alibozek AG, et al.
Am J Manag Care. 2013 Aug;19(8):617-24.
Am J Manag Care. 2013.
PMID: 24304211
Free article.
Item in Clipboard
Cite
Cite